The HM tumours had mutually exclusive mutations in B2M and HLA-A (FDR-adjusted P = 0.07)22, and co-occurring mutations in KMT2B and CD58 (FDR-adjusted P = 0.01) and ERBB3 (FDR-adjusted P = 0.09). The gene discussed is HLA-A; the disease is neoplasm.